DD246301A5 - Verfahren zur herstellung von 9-(2-hydroxyaethoxy-methyl)granin - Google Patents
Verfahren zur herstellung von 9-(2-hydroxyaethoxy-methyl)granin Download PDFInfo
- Publication number
- DD246301A5 DD246301A5 DD85284916A DD28491685A DD246301A5 DD 246301 A5 DD246301 A5 DD 246301A5 DD 85284916 A DD85284916 A DD 85284916A DD 28491685 A DD28491685 A DD 28491685A DD 246301 A5 DD246301 A5 DD 246301A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- compound
- formula
- acyl
- item
- leaving group
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 24
- 238000000034 method Methods 0.000 claims abstract description 22
- 125000006239 protecting group Chemical group 0.000 claims abstract description 4
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 24
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims description 2
- 239000003849 aromatic solvent Substances 0.000 claims description 2
- 239000003054 catalyst Substances 0.000 claims description 2
- 150000008282 halocarbons Chemical class 0.000 claims description 2
- 239000012429 reaction media Substances 0.000 claims description 2
- 125000002252 acyl group Chemical group 0.000 claims 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 230000007062 hydrolysis Effects 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 abstract description 12
- 238000002360 preparation method Methods 0.000 abstract description 8
- 239000003814 drug Substances 0.000 abstract description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 24
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 20
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 10
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 229960004150 aciclovir Drugs 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- -1 1-substituted purines Chemical class 0.000 description 3
- DRSHXJFUUPIBHX-UHFFFAOYSA-N COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 Chemical compound COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 DRSHXJFUUPIBHX-UHFFFAOYSA-N 0.000 description 3
- 229940015043 glyoxal Drugs 0.000 description 3
- GILZZWCROUGLIS-UHFFFAOYSA-N n-(9-acetyl-6-oxo-3h-purin-2-yl)acetamide Chemical compound N1C(NC(=O)C)=NC(=O)C2=C1N(C(C)=O)C=N2 GILZZWCROUGLIS-UHFFFAOYSA-N 0.000 description 3
- NYYDZOSYLUOKEM-UHFFFAOYSA-N oxaldehyde;hydrate Chemical compound O.O=CC=O NYYDZOSYLUOKEM-UHFFFAOYSA-N 0.000 description 3
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 1
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 description 1
- WJSVJNDMOQTICG-UHFFFAOYSA-N 2-amino-1-[(2-methyl-4-methylidene-5-oxooxolan-2-yl)methyl]-7h-purin-6-one Chemical class NC1=NC=2N=CNC=2C(=O)N1CC1(C)CC(=C)C(=O)O1 WJSVJNDMOQTICG-UHFFFAOYSA-N 0.000 description 1
- TVZRAEYQIKYCPH-UHFFFAOYSA-N 3-(trimethylsilyl)propane-1-sulfonic acid Chemical compound C[Si](C)(C)CCCS(O)(=O)=O TVZRAEYQIKYCPH-UHFFFAOYSA-N 0.000 description 1
- PIBSUCDJIXOBRC-UHFFFAOYSA-N CC(=O)OC(=O)C(=O)OC(C)=O.O=C1NC(NC(=O)C)=NC2=C1NC=N2 Chemical compound CC(=O)OC(=O)C(=O)OC(C)=O.O=C1NC(NC(=O)C)=NC2=C1NC=N2 PIBSUCDJIXOBRC-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- LSACYLWPPQLVSM-UHFFFAOYSA-N isobutyric acid anhydride Chemical compound CC(C)C(=O)OC(=O)C(C)C LSACYLWPPQLVSM-UHFFFAOYSA-N 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- MXSMRDDXWJSGMC-UHFFFAOYSA-N n-(6-oxo-3,7-dihydropurin-2-yl)acetamide Chemical compound N1C(NC(=O)C)=NC(=O)C2=C1N=CN2 MXSMRDDXWJSGMC-UHFFFAOYSA-N 0.000 description 1
- QNXFUWFRTWSSOK-UHFFFAOYSA-N n-acetyl-n-(6-oxo-3,7-dihydropurin-2-yl)acetamide Chemical compound O=C1NC(N(C(C)=O)C(=O)C)=NC2=C1NC=N2 QNXFUWFRTWSSOK-UHFFFAOYSA-N 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- OENLEHTYJXMVBG-UHFFFAOYSA-N pyridine;hydrate Chemical compound [OH-].C1=CC=[NH+]C=C1 OENLEHTYJXMVBG-UHFFFAOYSA-N 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 229940107931 zovirax Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| YU219084A YU45690B (sh) | 1984-12-22 | 1984-12-22 | Postopek za pripravo 9-(2-hidroksietoksimetil)-gvanina |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD246301A5 true DD246301A5 (de) | 1987-06-03 |
Family
ID=25557168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD85284916A DD246301A5 (de) | 1984-12-22 | 1985-12-20 | Verfahren zur herstellung von 9-(2-hydroxyaethoxy-methyl)granin |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4701526A (ja) |
| JP (3) | JPS61155386A (ja) |
| AT (1) | AT386826B (ja) |
| CS (1) | CS272215B2 (ja) |
| DD (1) | DD246301A5 (ja) |
| DE (1) | DE3544461A1 (ja) |
| HU (1) | HU196207B (ja) |
| PL (1) | PL147434B1 (ja) |
| SU (1) | SU1454253A3 (ja) |
| YU (1) | YU45690B (ja) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0290630A4 (de) * | 1986-11-25 | 1990-02-26 | Inst Organicheskogo Sinteza Ak | 9-substituierte guanine. |
| EP0564006A3 (en) * | 1987-05-04 | 1993-12-15 | Krka Tovarna Zdravil | Process for preparing purine derivatives and novel purine derivatives |
| GB8724765D0 (en) * | 1987-10-22 | 1987-11-25 | Beecham Group Plc | Process |
| JPH0219546A (ja) * | 1988-07-01 | 1990-01-23 | Nippon Tungsten Co Ltd | 織機用ウォータージェットノズル |
| ES2047457B1 (es) * | 1992-08-03 | 1994-10-01 | Union Quimico Farma | Procedimiento para obtener aciclovir. |
| DE19839013B4 (de) | 1998-08-27 | 2004-08-26 | Degussa Ag | Verfahren zur Hestellung von Guanin |
| DE19857949A1 (de) | 1998-12-16 | 2000-06-21 | Degussa | Verfahren zur Herstellung von Guanin unter Druck |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4199574A (en) * | 1974-09-02 | 1980-04-22 | Burroughs Wellcome Co. | Methods and compositions for treating viral infections and guanine acyclic nucleosides |
| US4146715A (en) * | 1975-08-27 | 1979-03-27 | Burroughs Wellcome Co. | 2-amido-9-(2-acyloxyethoxymethyl)hypoxanthines |
| YU41079B (en) * | 1976-08-27 | 1986-12-31 | Wellcome Found | Process for the synthesis of substituted purine compounds |
| BE863525A (fr) * | 1977-02-14 | 1978-07-31 | Bristol Myers Co | Heterocyclopyrimidines |
| IL64501A (en) * | 1980-12-22 | 1985-07-31 | Astra Laekemedel Ab | 9-substituted 4-hydroxybutyl guanine derivatives,their preparation and antiviral use |
-
1984
- 1984-12-22 YU YU219084A patent/YU45690B/sh unknown
-
1985
- 1985-12-11 US US06/807,724 patent/US4701526A/en not_active Expired - Fee Related
- 1985-12-16 DE DE19853544461 patent/DE3544461A1/de not_active Withdrawn
- 1985-12-19 AT AT0368385A patent/AT386826B/de not_active IP Right Cessation
- 1985-12-19 SU SU853990801A patent/SU1454253A3/ru active
- 1985-12-20 JP JP60285863A patent/JPS61155386A/ja active Granted
- 1985-12-20 PL PL1985256987A patent/PL147434B1/pl unknown
- 1985-12-20 HU HU854923A patent/HU196207B/hu not_active IP Right Cessation
- 1985-12-20 CS CS859666A patent/CS272215B2/cs unknown
- 1985-12-20 DD DD85284916A patent/DD246301A5/de unknown
-
1991
- 1991-09-11 JP JP3258636A patent/JPH0714936B2/ja not_active Expired - Lifetime
- 1991-09-11 JP JP3258637A patent/JPH0714937B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61155386A (ja) | 1986-07-15 |
| US4701526A (en) | 1987-10-20 |
| AT386826B (de) | 1988-10-25 |
| CS966685A2 (en) | 1990-03-14 |
| HU196207B (en) | 1988-10-28 |
| JPH05255328A (ja) | 1993-10-05 |
| ATA368385A (de) | 1988-03-15 |
| JPH0529228B2 (ja) | 1993-04-28 |
| JPH0714936B2 (ja) | 1995-02-22 |
| SU1454253A3 (ru) | 1989-01-23 |
| DE3544461A1 (de) | 1986-07-03 |
| YU219084A (en) | 1987-08-31 |
| CS272215B2 (en) | 1991-01-15 |
| HUT41028A (en) | 1987-03-30 |
| JPH0714937B2 (ja) | 1995-02-22 |
| PL256987A1 (en) | 1988-03-03 |
| PL147434B1 (en) | 1989-06-30 |
| YU45690B (sh) | 1992-07-20 |
| JPH05255329A (ja) | 1993-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2315801B2 (de) | 2-Alkyl-3-acyl-pyrazolo [1,5-a] pyridine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneipräparate | |
| CH648559A5 (de) | Theophyllinderivate und verfahren zu deren herstellung. | |
| EP0264081A2 (de) | Oxadiazolylalkylpurin-Derivate, ihre Herstellung und ihre Verwendung in pharmazeutischen Mitteln | |
| DD246301A5 (de) | Verfahren zur herstellung von 9-(2-hydroxyaethoxy-methyl)granin | |
| DE3642830A1 (de) | Verfahren zur herstellung von pyrimidinen | |
| US4380632A (en) | Method of preparing quinolines, naphthyridines and other nitrogen bi-heterocyclic compounds | |
| DE2365302C3 (de) | Verfahren zur herstellung von 2- amino-nicotino-nitrilen | |
| JP2523351B2 (ja) | 置換尿素、それらの製造法および特にセルロ―ス繊維を高品位化するためのそれらの応用 | |
| DE2359773C2 (ja) | ||
| DD292003A5 (de) | Verfahren zum herstellen von 2-amino-oxazolin-verbindungen | |
| DE2841644C2 (ja) | ||
| CH628040A5 (de) | Verfahren zur herstellung neuer 4-hydroxy-2h-naphtho(2,1-e)-1,2-thiazin-3-carboxamid-1,1-dioxyde. | |
| US4182880A (en) | 1,8-Naphthyridine compounds and process for preparing the same | |
| US4826981A (en) | Process for preparing 9-(2-hydroxyethoxymethyl)-guanine | |
| DE60114889T2 (de) | Verfahren zur herstellung von fluconazole und kristallmodifikationen davon | |
| DE2122070A1 (de) | 1 Veratryl 4 methyl 5 athyl 7,8 dimethoxy 2,3 diazabicyclo eckige Klam mer auf 5,4,0 eckige Klammer zu undeca pentaen (1,3,6,8,10) und seine Verwendung | |
| EP0193066B1 (de) | Neue Ketosultame und Verfahren zu ihrer Herstellung | |
| EP0393499A1 (de) | Verfahren zur Herstellung von Carbovir und neue Zwischenprodukte dafür | |
| DE60004054T2 (de) | Neue verfahren zur herstellung von 17beta-hydroxy-17alpha-methyl-2-oxa-5alpha-androstane-3-on | |
| DE2708827A1 (de) | Substituierte purinverbindungen, verfahren zu ihrer herstellung und pharmazeutische zubereitungen | |
| DE3135728C2 (de) | Verfahren zur Herstellung von Apovincaminsäureestern | |
| DE4207234A1 (de) | Neue aminocarbonsaeure-derivate mit antiallergischer/antiasthmatischer wirkung und verfahren zu deren herstellung | |
| DE2845843C3 (de) | Verfahren zur Herstellung von 2,4-Dialkyl-4-hydroxy-23-di-hydrofuran-3onen | |
| AT349025B (de) | Verfahren zur herstellung von neuen naphthyridinderivaten und von deren saeureadditionssalzen | |
| DE2508965C2 (de) | 1'-Desmethyl-1'-(β-hydroxyäthyl)-clindamycin-2-palmitat, dessen Säureadditionssalze und Verfahren zu deren Herstellung |